Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic’s C1 Platform Capabilities for Fast, ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic's C1 Platform Capabilities for Fast, Scalable Biologic ProductionJUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic ...
Each time an epidemic emerges, the same question surfaces regarding its origin. And with every zoonotic disease, the question ...
Global health officials are tracking an outbreak of Ebola caused by a rare species of orthoebolavirus called the Bundibugyo ...
Bundibugyo virus is an uncommon species of Ebola-causing virus that has been linked to only two other known outbreaks ...
Trust and community engagement will be as important as vaccines in controlling the disease, say Daniela Manno and ...
As an Ebola outbreak in the Democratic Republic of Congo grows, the Trump administration says it is focused on keeping the ...
After a tense day of speculation, Gadsden Regional Medical Center has released a statement that there's no cases of viral ...
The ongoing Ebola outbreak in Congo’s Ituri province has nearly 600 suspected cases and over 100 deaths, with several Americans exposed to the highly contagious disease. One US citizen is confirmed to ...
By Julie Steenhuysen CHICAGO, May 22 (Reuters) - The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results